Abiopharma

Schingler Robert H 🔴 sold 54.1K shares of Planet Labs PBC (PL) at $30.58 ($1.7M) Transaction Date: Jun 15, 2026 | Filing ID: 274529

Director BIZZARI JEAN-PIERRE 🟢 acquired 15.7K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $0.73 Transaction Date: Jun 16, 2026 | Filing ID: 075281

Director Fleischhauer Mark 🔴 sold 3.5K shares of Anterix Inc. (ATEX) at $79.83 Transaction Date: Jun 15, 2026 | Filing ID: 000004

Director Duey Marc 🟢 acquired 15.7K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $0.73 Transaction Date: Jun 16, 2026 | Filing ID: 075280

Director Pamukcu Rifat 🟢 acquired 15.7K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $0.73 Transaction Date: Jun 16, 2026 | Filing ID: 075279

Director Seizinger Bernd R. 🟢 acquired 15.7K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $0.73 Transaction Date: Jun 16, 2026 | Filing ID: 075278

Marshall William Spencer 🔴 sold 134.6K shares of Planet Labs PBC (PL) at $30.58 ($4.1M) Transaction Date: Jun 15, 2026 | Filing ID: 274526

Director YAZDI MAHVASH 🔴 sold 7.0K shares of Anterix Inc. (ATEX) at $80.00 Transaction Date: Jun 16, 2026 | Filing ID: 000007

Testa Michael 🔴 sold 2.6K shares of Trinity Capital Inc. (TRIN) at $16.89 Transaction Date: Jun 15, 2026 | Filing ID: 274521

Brown Kyle Steven 🔴 sold 10.7K shares of Trinity Capital Inc. (TRIN) at $16.89 Transaction Date: Jun 15, 2026 | Filing ID: 274520